Shares of Jade Biosciences, Inc. (JBIO) have gained 25% over the past four weeks to close the last trading session at $12, but there could still be a solid upside left in the stock if short-term price ...

The average one-year price target for Jade Biosciences (NasdaqCM:JBIO) has been revised to $19.38 / share. This is an increase of 13.43% from the prior estimate of $17.08 dated September 27, 2025. The ...

The latest price target for Jade Biosciences (NASDAQ:JBIO) was reported by Clear Street on November 25, 2025. The analyst firm set a price target for $25.00 expecting JBIO to rise to within 12 months ...

Jade Currency, incorporated by Crypto Jade LLC in 2017, is an online marketplace that specifically targets the precious gem and cryptocurrency industries. Its native cryptocurrency token, JADE, is ...

Jade Biosciences, Inc. (Nasdaq: JBIO), a biotechnology company focused on autoimmune disease therapies, has announced the successful completion of its reverse merger and its debut on Nasdaq, along ...